BI 3034701

DRUG4 trials

Sponsors

Boehringer Ingelheim

Conditions

HealthyObesityOverweight

Phase 1

A Study to Test How Well Different Doses of BI 3034701 Are Tolerated by Healthy Men and People With Overweight or Obesity

CompletedNCT06352437

Boehringer IngelheimHealthy

Start: 2024-06-10End: 2025-10-07Updated: 2025-11-21

A Study to Test How Well Different Doses of BI 3034701 Are Tolerated by Japanese Healthy People and Japanese People With Obesity or Overweight

RecruitingNCT07693231

Boehringer IngelheimHealthy, Obesity

Start: 2026-07-21End: 2027-01-05Target: 48Updated: 2026-07-24

A Study to Test How Well Different and Multiple Doses of BI 3034701 Are Tolerated in People Living With Overweight or Obesity

Not yet recruitingNCT07754474

Boehringer IngelheimObesity, Overweight

Start: 2026-09-01End: 2027-06-21Target: 70Updated: 2026-09-03

Phase 2

A Study to Test Whether BI 3034701 Helps People to Lose Weight Who Live With Obesity or Overweight

Active, not recruitingNCT07662122

Boehringer IngelheimObesity, Overweight

Start: 2026-06-30End: 2027-08-18Updated: 2026-09-10